Protective Cellular Immunity against a Spontaneous Mammary Carcinoma from ras Transgenic Mice

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

1983 • 1,307 citations

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1984 • 884 citations

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo

1987 • 796 citations

ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS*

1962 • 528 citations

Antigenicity of Murine Skin Tumors Induced by Ultraviolet Light2

1974 • 484 citations

Biologic Therapy of Cancer

1992 • 476 citations

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.

1994 • 363 citations

Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus

1981 • 303 citations

Accumulation of genetic alterations and progression of primary breast cancer.

1991 • 229 citations

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.

1989 • 223 citations

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins.

1991 • 208 citations

Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.

1985 • 185 citations

Peptide-Binding Heat Shock Proteins in the Endoplasmic Reticulum: Role in Immune Response to Cancer and in Antigen Presentation

1993 • 167 citations

Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization

1979 • 129 citations

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.

1991 • 126 citations

Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation.

1984 • 107 citations

Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.

1989 • 101 citations

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

1987 • 98 citations

Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.

1990 • 91 citations

Nonvirus-associated antigens in virus-induced mouse mammary tumors.

1968 • 62 citations

Demonstration of Tumor-Specific Immunity Against Antigens Unrelated to the Mammary Tumor Virus in Spontaneous Mammary Adenocarcinomas<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

1969 • 58 citations

Immunogenic Properties of Reticulum Cell Sarcomas of SJL/J Mice<xref ref-type="fn" rid="FN2">2</xref>

1970 • 56 citations

Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors.

1990 • 42 citations

The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C57Bl mice

1968 • 38 citations

Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.

1987 • 33 citations

The therapeutic significance of concomitant antitumor immunity

1984 • 27 citations

Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.

1988 • 25 citations

Demonstration of tumorspecific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas

1969 • 25 citations

Surveillance, latency and the two levels of MCA‐induced tumor immunogenicity

1987 • 24 citations

Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.

1991 • 12 citations

Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.

1990 • 5 citations